Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

11.01
Delayed Data
As of Sep 22
 +0.09 / +0.82%
Today’s Change
6.90
Today|||52-Week Range
11.63
+28.47%
Year-to-Date
No recent news for Neogenomics Inc.

Today’s Trading

Previous close10.92
Today’s open10.91
Day’s range10.61 - 11.16
Volume324,196
Average volume (3 months)336,703
Market cap$874.1M
Dividend yield--
Data as of 4:00pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)-875.00%
Earnings growth (this year)+22.00%
Earnings growth (next 5 years)+27.50%
Revenue growth (last year)+144.57%
P/E ratioNM
Price/Sales2.72
Price/Book5.28

Competitors

 Today’s
change
Today’s
% change
NTRANatera Inc+0.30+2.47%
ENZEnzo Biochem Inc-0.01-0.10%
KANGiKang Healthcare Gro...+0.01+0.07%
RDNTRadNet Inc+0.10+0.91%
Data as of 4:02pm ET, 09/22/2017

Financials

Next reporting dateNovember 2, 2017
EPS forecast (this quarter)$0.04
Annual revenue (last year)$244.1M
Annual profit (last year)-$5.7M
Net profit margin-2.34%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
Executive Chairman &
Chief Executive Officer
Douglas M. Van Oort
Chief Scientific Officer &
VP-Operations
Steven G. Brodie
Corporate headquarters
Fort Myers, Florida

Forecasts